Capital Raise
USD 14 mn
FY27
Exclusive financial advisor to QuickClean on its Series B fundraise
Ambit acted as the exclusive financial advisor to QuickClean on its USD 14 Mn Series B fundraise led by Stakeboat Capital, with participation from existing investors Alkemi Growth Capital and Blue Ashva Capital
Exclusive financial advisor to QuickClean on its Series B fundraise
Ambit acted as the exclusive financial advisor to QuickClean on its USD 14 Mn Series B fundraise led by Stakeboat Capital, with participation from existing investors Alkemi Growth Capital and Blue Ashva Capital
ECM
INR 2.45 bn
FY27
Sole BRLM to IPO of PropShare Celestia Scheme
Ambit acted as sole book running lead manager for IPO of the third scheme of Property Share Investment Trust - PropShare Celestia (SM-REIT) aggregating to c. INR 2.45 bn
Sole BRLM to IPO of PropShare Celestia Scheme
Ambit acted as sole book running lead manager for IPO of the third scheme of Property Share Investment Trust - PropShare Celestia (SM-REIT) aggregating to c. INR 2.45 bn
M&A
NA
FY27
Advisor to Macquarie Asset Management on acquisition of CDPQ's Stake of upto c.37.5% in Maple Infrastructure Trust
Ambit acted as an advisor to Macquarie Asset Management on acquisition of CDPQ's Stake of upto c.37.5% in Maple Infrastructure Trust
Advisor to Macquarie Asset Management on acquisition of CDPQ's Stake of upto c.37.5% in Maple Infrastructure Trust
Ambit acted as an advisor to Macquarie Asset Management on acquisition of CDPQ's Stake of upto c.37.5% in Maple Infrastructure Trust
ECM
INR 1.23 bn
FY27
Advisor and Broker to Sunil Sachdeva for sale of shares of Global Health (Medanta)
Advisor and Broker to Sunil Sachdeva for sale of 1mn shares of Global Health (Medanta) aggregating to c. INR 1.23 bn
Advisor and Broker to Sunil Sachdeva for sale of shares of Global Health (Medanta)
Advisor and Broker to Sunil Sachdeva for sale of 1mn shares of Global Health (Medanta) aggregating to c. INR 1.23 bn
ECM
INR 11 bn
FY27
Book Running Lead Manager for IPO of Citius TransNet Investment Trust
Ambit acted as the BRLM to INR 11 bn IPO of Citius TransNet Investment Trust. Launched amid subdued IPO market, yet saw strong Long-only investor participation, reflecting confidence in Citius TransNet InvIT’s story
Book Running Lead Manager for IPO of Citius TransNet Investment Trust
Ambit acted as the BRLM to INR 11 bn IPO of Citius TransNet Investment Trust. Launched amid subdued IPO market, yet saw strong Long-only investor participation, reflecting confidence in Citius TransNet InvIT’s story
ECM
INR 5.0 bn
FY27
Left Lead Manager for the QIP of Manorama Industries Limited
Ambit acted as the Left Lead Manager to INR 5 bn Qualified Institutions Placement of Manorama Industries Limited and leading end-to-end transaction execution
Left Lead Manager for the QIP of Manorama Industries Limited
Ambit acted as the Left Lead Manager to INR 5 bn Qualified Institutions Placement of Manorama Industries Limited and leading end-to-end transaction execution
M&A
INR 4.73 bn
FY26
Exclusive financial advisor on the strategic acquisition of 24 Mantra by ITC Ltd.
Ambit acted as the exclusive financial advisor to selling shareholders of Sresta Natural Bioproducts Pvt. Ltd., the parent company of the 24 Mantra Organic brand, in its strategic acquisition by ITC Ltd.
Exclusive financial advisor on the strategic acquisition of 24 Mantra by ITC Ltd.
Ambit acted as the exclusive financial advisor to selling shareholders of Sresta Natural Bioproducts Pvt. Ltd., the parent company of the 24 Mantra Organic brand, in its strategic acquisition by ITC Ltd.
ECM
INR 10 bn
FY26
Book Running Lead Manager for IPO of Nephrocare Health Services Limited
Ambit acted as a BRLM to the c.INR 10 bn IPO consisting of secondary pre-IPO of INR 1.36 bn, a Fresh Issue of INR 3.53 bn and an Offer for Sale of INR 5.18 bn.The anchor book witnessed participation from Tier 1 MFs as well as Long Only FIIs, showcasing strong Investor conviction in the Nephroplus story
Book Running Lead Manager for IPO of Nephrocare Health Services Limited
Ambit acted as a BRLM to the c.INR 10 bn IPO consisting of secondary pre-IPO of INR 1.36 bn, a Fresh Issue of INR 3.53 bn and an Offer for Sale of INR 5.18 bn.The anchor book witnessed participation from Tier 1 MFs as well as Long Only FIIs, showcasing strong Investor conviction in the Nephroplus story
M&A
INR 1.5 bn
FY26
Exclusive financial advisor to Société BIC on sale of its subsidiary BIC Cello (India) Pvt. Ltd.
Ambit acted as the exclusive financial advisor to to Société BIC on sale of its subsidiary BIC Cello (India) Pvt. Ltd. to buyer consortium led by Authum Investment & Infrastructure Ltd.
Exclusive financial advisor to Société BIC on sale of its subsidiary BIC Cello (India) Pvt. Ltd.
Ambit acted as the exclusive financial advisor to to Société BIC on sale of its subsidiary BIC Cello (India) Pvt. Ltd. to buyer consortium led by Authum Investment & Infrastructure Ltd.